# Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

> **NCT01343485** · NA · COMPLETED · sponsor: **Planned Parenthood Federation of America** · enrollment: 365 (actual)

## Conditions studied

- GARDASIL Vaccination

## Interventions

- **BEHAVIORAL:** Computer reminder system

## Key facts

- **NCT ID:** NCT01343485
- **Lead sponsor:** Planned Parenthood Federation of America
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2018-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01343485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01343485, "Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01343485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*